On May 7, 2026, the U.S. Food and Drug Administration (FDA) announced a massive operational overhaul, integrating advanced artificial intelligence and unified data platforms to accelerate regulatory science. This technological leap coincides with a major update from the Center for Tobacco Products (CTP), which confirmed that new efficiencies have already drastically reduced premarket tobacco product application (PMTA) review times.
Read moreTag Archive for: PMTA
The U.S. Food and Drug Administration (FDA) has introduced fully web-based versions of four key regulatory forms for premarket tobacco product applications (PMTAs) and Substantial Equivalence (SE) Reports. This update to the CTP Portal Next Generation (CTP Portal NextGen) allows manufacturers to complete, validate, and submit Forms FDA 4057, 4057a, 3965, and 3965a entirely online.
Read moreThe Acting Director of the U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP), Bret Koplow, has signaled a potential shift in the agency’s approach to tobacco control, expressing support for a “tobacco harm reduction” strategy to lower cigarette smoking rates. Speaking at the Food and Drug Law Institute (FDLI) conference, Koplow stated he “carefully supports” the potential for expanding the range of authorized flavored e-cigarettes.
Read moreA bill aimed at restricting e-cigarette sales in Pennsylvania is currently awaiting a vote in the State Senate. The proposed legislation would create a state-managed database listing all certified manufacturers and vape products that are legal to sell within the commonwealth.
Read moreNJOY LLC, a subsidiary of tobacco giant Altria Group, has filed a federal lawsuit against the U.S. Food and Drug Administration (FDA), accusing the agency of unlawfully delaying its review of applications to market flavored e-cigarettes. The lawsuit, filed on August 21, 2025, in the Western District of Louisiana, argues that the FDA’s inaction has effectively created a “de facto flavor ban” on NJOY’s products, hindering its ability to provide adult smokers with reduced-risk alternatives while allowing a flood of unauthorized, illicit flavored disposable vapes to dominate the U.S. market.
Read moreThe U.S. Food and Drug Administration (FDA) has denied marketing rights for the Blu disposable classic tobacco-flavored 2.4% nicotine e-cigarette, according to a recent agency announcement. The product, produced by Fontem US, cannot be legally marketed in the United States.
Read moreAbout Ecigator
About Us
Business
- Authentication Check
- Press Release
- Store Location
- Stag Bar Vape